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Abstract The apolipoprotein A-I (apoA-I) solution structure in
the presence of sodium dodecyl sulfate (SDS) was determined by
combination of chemical shift index and torsion angle likelihood
obtained from shift and sequence similarity methods. ApoA-I in
lipid-mimetic solution is composed of K-helices (residues 8^32,
45^64, 67^77, 82^86, 90^97, 100^118, 122^140, 146^162, 167^
205, 210^216 and 221^239), with 2^5 residue irregular segments
between helical repeats, and the irregular segment 78^81 within
helical repeat 2. ApoA-I is a monomer in the SDS complex and
no evidence of interhelical interactions is found. Comparison of
the apoA-I and apoA-I(1^186) [Okon et al., FEBS Lett. 487
(2001) 390^396] solution structures revealed that apoA-I under-
goes a conformational change around Pro121. ß 2002 Pub-
lished by Elsevier Science B.V. on behalf of the Federation of
European Biochemical Societies.
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1. Introduction
Apolipoprotein A-I (apoA-I) is a single polypeptide of
243 amino acid residues, and the major constituent in high
density lipoprotein (HDL), comprising approximately 70% of
total protein. A key metabolic role of apoA-I is its ability to
activate lecithin:cholesterol acyltransferase, an enzyme which
transesteri¢es the sn-2 fatty acid from phosphatidylcholine to
cholesterol to yield cholesteryl esters [1]. ApoA-I has also
been suggested as a probable ligand for the HDL receptor,
SR-BI, [2] and to play a central regulatory role in cholesterol
e¥ux [3,4]. ApoA-I is hydrophobic, aggregates in aqueous
solution, and has two 11 and eight 22 residue tandem repeats,
which were proposed to form amphipathic helices with dis-
tinct hydrophilic and hydrophobic faces [5]. Based upon pri-
mary sequence analysis, and circular dichroism and infrared
results, a secondary structure of apoA-I was predicted wherein
the tandem repeats formed antiparallel helical regions linked
by short, tight turns [6,7]. Adjacent helices were proposed to
be close enough to form salt bridges [8]. Recently, the X-ray
structure of lipid-free tetramers of the N-terminal deletion
mutant apoA-I(44^243) has been reported by Borhani et al.
[9].
In the present communication we report the solution sec-
ondary structure of isotopically labeled apoA-I determined by
multidimensional heteronuclear nuclear magnetic resonance
(NMR) in a lipid-mimetic environment of excess sodium do-
decyl sulfate (SDS). The secondary structure of intact apoA-I
is compared with our recently published solution secondary
structure of apoA-I(1^186) in SDS [10].
2. Materials and methods
2.1. Sample production and puri¢cation
The [u-13C, u-15N]apoA-I sample, including the N-terminal exten-
sion Met-Arg-Gly-Ser-(His)6-Met [11], was expressed in a bacterial
system described earlier [12], using Martek 9-CN media containing
98% 13C and 98% 15N (Martek Biosciences, Columbia, MD, USA).
[u-15N] apoA-I was prepared in the same system using [u-15N] Martek
9. ApoA-I plus leader had a molecular weight of 29 500. After puri-
¢cation on nitriloacetic acid agarose (NTA, from Qiagen, Valencia,
CA, USA), the uniformly labeled protein (7.5 mg/l media) was dia-
lyzed against 5 mM NH4HCO3, and lyophilized.
2.2. Circular dichroic measurements
Circular dichroic spectroscopy was performed using a Jasco J41A
spectropolarimeter, as previously described [13]. The percentage of
K-helix content was calculated from the molar ellipticity at 222 nm,
using a mean residue weight of 115.2 for native apoA-I.
2.3. NMR spectroscopy and structure analysis
The samples used in the NMR studies were: 2 mM [u-15N]apoA-I
in 95% H2O:5% D2O solution, pH 6.5 (sample A) and 2 mM [u-13C,
u-15N]apoA-I in 95% H2O:5% D2O solution (sample B). The temper-
atures of both samples and pH values of sample B were varied. The
pH values were adjusted by adding small amounts of 0.1 N HCl or
NaOH. All solutions contained SDS-d25 ; protein:SDS ratio 1:140
mol/mol. The NMR spectra were recorded on a Bruker AMX-600
spectrometer operating at 600.13 MHz (1H) and equipped with a
Z-gradient triple-resonance probe. In all experiments quadrature de-
tection in the indirectly detected dimensions was obtained using
States-TPPI [14], modi¢ed to give additional suppression of axial
peaks [15]. The following experiments, and their modi¢cations to
the published procedures, were applied to samples A and B (the sam-
ple conditions are denoted in parentheses).
A two-dimensional (2D) 1H/15N heteronuclear single quantum co-
herence (HSQC) spectrum with water suppression by gradient-tailored
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excitation (WATERGATE) [16] of sample A was acquired at 49‡C
(64 transients) with 256U256 complex points and spectral widths of
3.095 ppm (HN) and 24.00 ppm (15N) with carrier positions at 8.3 and
116.6 ppm, respectively.
The 3D 15N-edited total correlation spectroscopy (TOCSY)^HSQC
spectrum [17] of sample A was acquired at 40 and 50‡C and per-
formed with the DIPSI-2rc isotropic mixing sequence [18] using a
mixing time of 86 ms. The 3D 15N-edited gradient-enhanced nuclear
Overhauser enhancement spectroscopy (NOESY)^HSQC [19] spec-
trum was obtained for sample A at 40‡C and recorded as described
previously [10]. 3D 15N-edited NOESY^HSQC spectra were obtained
for sample A at 40, 50 and 57‡C and for sample B (pH 6.0 and 7.0 at
both 42 and 52‡C, pH 8.0 at 42‡C). The pulse sequence was based on
a 3D 15N-edited NOESY^HMQC pulse sequence [20] with the follow-
ing modi¢cations: (i) an HSQC step was inserted instead of HMQC,
(ii) pulse ¢eld gradients were used to minimize artefacts [21], and (iii)
the WATERGATE pulse sequence [16] was used to suppress the
water signal. The 3D 15N/15N-edited NOESY^HSQC spectrum of
sample A (42‡C) was recorded as a variant of the XTONOX experi-
ment [22], where the TOCSY evolution period was omitted.
The 3D spectra of sample B, HNCO, HNCA and HN(CO)CA [23]
(pH 6.0 and 7.0 at both 42 and 52‡C, pH 8.0 at 42‡C), and the
CBCA(CO)NH [24] and HN(COCA)HA [25] spectra (pH 7.0,
42‡C), were recorded as described previously [10]. The 3D HNHA
spectrum [26] of sample A (50‡C) was acquired (48 transients) with
256 (HN)U48 (1H)U40 (15N) complex points and spectral widths of
2.7 (HN), 6.1 (1H) and 24.0 (15N) ppm.
The 4D 15N/15N-edited NOESY experiment was applied only to
sample A. The pulse sequence for this experiment was based on a
13C/13C-edited NOESY experiment [27]. All NOESY spectra were
recorded with a mixing time of 150 ms.
The numbers of scans were eight to 96 for 3D and two for 4D
experiments. Proton chemical shifts were referenced to internal 2,2-
dimethyl-2-silapentane-5-sulfonic acid (DSS) directly, and 13C and
15N chemical shifts were indirectly referenced to DSS [28]. Data
were processed and analyzed on an SGI O2 workstation using
nmrPipe/nmrDraw [29] and NMRView3 [30]. ApoA-I spectra were
assigned in the same way as we used to assign apoA-I(1^186) spectra
[10]. The apoA-I secondary structure was determined from the chem-
ical shift values using the chemical shift index (CSI) method [28,31^33]
and the torsion angle likelihood obtained from shift and sequence
similarity (TALOS) program [34].
To compare apoA-I and apoA-I(1^186) at the same conditions
(1 mg/ml, pH 6.4, 39‡C, protein:SDS ratio 1:140 mol/mol), three
additional 3D apoA-I spectra ^ (HB)CBCA(CO)HN, HNCACB
[35,36] and HNCO ^ were recorded on a Varian Unity-Inova
NMR-spectrometer operating at 599.76 MHz (1H) and equipped
with an X-, Y- and Z-gradient triple-resonance probe.
Fig. 1. 2D 1H^15N HSQC correlation spectrum of apoA-I. The cross-signals, mainly representing one amino acid, are labeled with their residue
name and number. The signals from N1H of Trp side chains are in rectangle in the left bottom corner. Folded in 15N dimension peaks from
Arg side chains are in the circle. NH2 signals from Asn and Gln side chains are connected by straight lines. Signals labeled NP184, NP241 and
QP243 are assigned to deamidated forms of apoA-I with N184 and N241 replaced by D184 and D241, respectively. Signals labeled S-7 and G-8
belong to the aminoterminal tag, and labeled ‘x’ to unassigned impurity. Vertical noise at 8.5 ppm arises from folded residual H2O signal. In-
tensity of cross-peak from Ala 130 is lower than selected cuto¡ and its position is denoted by a small square.
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3. Results and discussion
3.1. Global characteristics of apoA-I NMR spectra in SDS
solution and tertiary organization of apoA-I
The salient feature of apoA-I NMR spectra in solution is
the small chemical shift dispersion. The majority of the HN
signals are found in the narrow range between 8.5 and 7.5
ppm (Fig. 1). The chemical shift range for signals from
apoA-I amino acid side chains is also quite narrow. For ex-
ample, 37 CNH3 Leu and 13 CQH3 Val signals are all distrib-
uted in a narrow range of 0.8^1.1 ppm, indicating the absence
of any possible ring current shifts that could be induced by
long range interhelical hydrophobic interactions between
50 aliphatic and 22 aromatic side chains in the tertiary
Fig. 2. Summary of structural information obtained from NMR spectra at pH 7.0, 42‡C. From bottom to top: consensus of 1HK, 13CK and
13CP CSI values; x (¢lled circles) and 8 (open circles) angle values predicted by TALOS; apoA-I solution secondary structure (K-helices are de-
picted by rectangles and irregular regions by lines). The average backbone torsion angles among all well-de¢ned K-helices (RMSD 9 8‡) are:
xaver =363.2 þ 2.0 and 8aver =341.9 þ 2.1 degrees.
Fig. 3. Chemical shift perturbations (v) de¢ned as sum of the absolute values of the backbone HN, 15N, 13CK and 13CP chemical shift di¡eren-
ces due to di¡erent lengths of apoA-I (chemical shifts of apoA-I(1^186) and apoA-I taken under the same conditions (1 mg/ml, pH 6.4, 39‡C,
protein:SDS ratio 1:140 mol/mol) are compared).
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apoA-I structure. The most likely explanation is that lipid-
bound apoA-I is in a ‘molten globular-like’ state with the K-
helices being relatively weakly stabilized by tertiary interac-
tions, as was suggested for lipid-free apoA-I structure [37].
3.2. Secondary structure of apoA-I in SDS solution
Both CSI and TALOS predict a predominantly K-helical
structure for the protein in a lipid environment (Fig. 2). The
results are almost identical to those we determined for apoA-
I(1^186) in SDS [10]. CSI values of zero are found for 2^5
residues between helical repeats and are accompanied by de-
viation from the ideal K-helical values of TALOS-predicted
torsion angles with increased root mean square deviations
(RMSD; Fig. 2). These regions we denote as irregular struc-
tures, i.e. as regions with no well-de¢ned structure. The irreg-
ular structures occur between the helical repeats predicted by
Segrest and coworkers [5]. We also calculated apoA-I struc-
tures at pH 6.0, 42‡C and at pH 7.0, 52‡C. Although the CSI
values remain unchanged with pH and temperature, TALOS
predicts that the irregular regions become ‘more helical’ at pH
6.0, especially regions 78^81, 87^89 and 208^209.
Indication that spontaneous deamidation of apoA-I takes
place at Asn184 and Asn241 positions was indicated from
comparison of HNCA, HN(CO)CA and CBCA(CO)NH spec-
tra of apoA-I. The deamidation is accompanied by perturba-
tions of backbone chemical shifts of 5^10 residues situated (in
the apoA-I secondary structure) around deamidated residues.
3.3. Local characteristics of apoA-I NMR spectra and
comparison of apoA-I and apoA-I(1^186) structures
Analysis of the apoA-I NMR spectra shows that resonance
lines from residues constituting helical repeats 4 and 5 (resi-
dues 100^140) have smaller intensities then the lines from the
rest of the protein. Such behavior is usually the characteristic
of unstable structure with intermediate exchange rates be-
tween existing conformers, and we would expect to observe
conformational and/or spectral changes from the region when
conditions vary.
Indeed, comparing apoA-I and apoA-I(1^186) [10] we ¢nd
that the di¡erence between the two structures is in the region
around Pro121, which is the midpoint between helices 4 and 5.
The strong chemical shift perturbations in the region re£ect
this fact (Fig. 3). It can be seen that the perturbations mono-
tonically decrease to either side of Pro121. The 13CK chemical
shift of Glu120 undergoes an especially strong perturbation,
3.9 ppm up¢eld in apoA-I compared with apoA-I(1^186).
Such a large shift, together with up¢eld 13CK shift of 1.5
ppm for Val119, indicates a more extended structure around
Pro121 in apoA-I. It is interesting to note that TALOS pre-
dicts a Val119 conformational change from helical (for apoA-
I(1^186)) to extended (for apoA-I at 52‡C). The chemical shift
perturbations for residues near Glu78 in the sequence (Fig. 3)
do not result in any prediction of a structure change for the
region and seemingly re£ect only the unstable nature of the
region.
Apparently, the structure of apoA-I(1^186) is more ‘rigid’
in the region around Pro121. The result is consistent with the
data obtained by the limited proteolysis of lipid-free apoA-I
and apoA-I(1^186). The minor cleavage sites in apoA-I, in-
cluding Leu122, were not found in apoA(1^186) [38]. The
NMR evidence strongly suggests apoA-I undergoes a confor-
mational change around the Pro121 position as conditions
vary. Existence of a mobile domain composed of residues
99^143 was proposed from investigation of the immunoreac-
tivity of a series of epitopes distributed along the sequence in
lipid-free and lipid-bound forms of apoA-I [39].
Our NMR-derived apoA-I structure in lipid-mimetic solu-
tion closely resembles the crystal structure except for the ir-
regular segments between helical repeats. We also see no evi-
dence showing eight amino acids in the last 22-mer repeat of
apoA-I (residues 220^227) in an extended, non-helical confor-
mation as indicated by the crystal structure [9]. On the con-
trary, NMR gives a very well-de¢ned helix for residues 221^
227.
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